NewAmsterdam Pharma Company N.V. Ordinary Shares Share Price
NASDAQ: NAMS | Mid CapNewAmsterdam Pharma Company N.V. Ordinary Shares Stock Performance
Open $27.88 | Prev. Close $27.59 | Circuit Range N/A |
Day Range $27.56 - $28.20 | Year Range $22.29 - $42.10 | Volume 42,542 |
Average Traded $27.84 |
NewAmsterdam Pharma Company N.V. Ordinary Shares Share Price Today
As of 10 August 2026, NewAmsterdam Pharma Company N.V. Ordinary Shares's share price is $27.96. The stock opened at $27.88, compared to its previous close of $27.59. During today's trading session, NewAmsterdam Pharma Company N.V. Ordinary Shares's share price traded between $27.56 and $28.20, with an average price of $27.88. Over the past 52 weeks, the stock has recorded a high of $42.10 and a low of $22.29. In terms of performance, NewAmsterdam Pharma Company N.V. Ordinary Shares's share price has declined by 21.15% over the last six months and is up 16.38% on a year-on-year basis.
NewAmsterdam Pharma Company N.V. Ordinary Shares Share Price Chart
NewAmsterdam Pharma Company N.V. Ordinary Shares Stock Fundamentals & Key Indicators
Market Cap $3.31B | PE Ratio (TTM) -16.26 | Dividend Yield N/A |
EPS (TTM) $-1.72 | Revenue (TTM) $22.50M | Return On Equity (TTM) -29.82% |
Profit Margin -905.74% | Debt to Equity 0.13 | Quarterly Earnings Growth YoY N/A |
NewAmsterdam Pharma Company N.V. Ordinary Shares Quarterly Profit & Loss
All figures in USD
NewAmsterdam Pharma Company N.V. Ordinary Shares Annual Profit & Loss
All figures in USD
About NewAmsterdam Pharma Company N.V. Ordinary Shares
NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with metabolic disease. It is developing obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is in Phase 2a clinical trial for Alzheimer's disease. NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands.
NewAmsterdam Pharma Company N.V. Ordinary Shares Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $27.48 | $27.95 | +0.65% |
Jul 2026 | $34.41 | $27.77 | -18.15% |
Jun 2026 | $32.71 | $33.92 | +0.76% |
May 2026 | $29.11 | $33.66 | +17.92% |
Apr 2026 | $32.50 | $28.55 | -10.78% |
Mar 2026 | $34.81 | $32.00 | -9.76% |
Feb 2026 | $30.77 | $35.46 | +13.84% |
Jan 2026 | $35.20 | $31.15 | -11.20% |
Dec 2025 | $40.69 | $35.08 | -15.04% |
Nov 2025 | $37.73 | $41.29 | +8.83% |
Oct 2025 | $28.39 | $37.94 | +33.73% |
Sep 2025 | $24.04 | $28.37 | +18.09% |
NAMS Share Price FAQs
What is NewAmsterdam Pharma Company N.V. Ordinary Shares share price today?
What is the 52 week high and 52 week low of NewAmsterdam Pharma Company N.V. Ordinary Shares stock?
What is NAMS's market capitalisation today?
What is NAMS's net income for the last quarter?
What is the 5 year returns of NAMS?
What is the high & low stock price of NAMS today?
Can I buy NAMS shares in India?